Aberrant CpG island methylation of multiple genes in ependymal tumors

Journal of Neuro-Oncology

Volumn 67, Issue 1-2, 2004, Pages 159-165

  Alonso, M Eva ^a   Bello, M Josefa ^a   Gonzalez Gomez, Pilar ^a   Arjona, Dolores ^a   de Campos, Jose M ^b   Gutierrez, Manuel ^a   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Aberrant methylation; CpG island; Ependymoma; MGMT; p16INKA4a; RB1; THBS1

Indexed keywords

CASPASE 8; CELL DNA; DEATH ASSOCIATED PROTEIN KINASE; MERLIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16; PROTEIN P73; RETINOBLASTOMA PROTEIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL CYCLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPENDYMOMA; FEMALE; FREQUENCY ANALYSIS; GENE INACTIVATION; GENE NUMBER; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MULTIGENE FAMILY; ONCOGENE; PROMOTER REGION; REGULATORY MECHANISM; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CPG ISLANDS; DNA METHYLATION; EPENDYMOMA; FEMALE; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 1842536823     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000021862.41799.f7     Document Type: Article

References (43)

1. Kleihues P, Cavenee WK: Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer, Lyon, France, 2000
2. Horn B, Heideman R, Geyer R, Pollack I, Packer R, Goldwein J, Tomita T, Schomberg P, Ater J, Luchtman-Jose L, Rivlin K, Lamborn K, Prados M, Bollen A, Berger M, Dahl G, McNeil E, Petterson K, Shaw D, Kubalik K, Russo C: A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Peadiatr Hematol Oncol 21: 203-211, 1999
3. Rubio M-P, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN: Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54: 45-47, 1994
4. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A: Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155: 627-632, 1999
5. Alonso ME, Bello MJ, Arjona D, Gonzalez-Gomez P, Lomas J, de Campos JM, Kusak ME, Isla A, Rey JA: Analysis of the NF2 gene in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 134: 1-5, 2002
6. Hulsebos TJM, Oskam NT, Bijleveld EH, Westerveld A, Hermsen MA, van den Ouweland AMW, Hamel BC, Tijssen CC: Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2. Br J Cancer 81: 1150-1154, 1999
7. Rousseau-Merk M, Versteege I, Zattara-Cannoni H, Figarella D, Lena G, Aurias A, Vagner-Capodano A: Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas. Cancer Genet Cytogenet 121: 223-227, 2000
8. Weremowicz S, Kupsky WJ, Morton CC, Fletcher JA: Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet 61: 193-196, 1992
9. Kraus JA, de Millas W, Sörensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A, Pietsch T: Indications for a tumors suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INII. Acta Neuropathol 102: 69-74, 2001
10. Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG: Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158: 1137-1143, 2001
11. Scheill S, Brüderlein S, Eicker M, Herms J, Herold-Mende C, Steiner H-H, Barth TFE, Möller P: Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 11: 133-143, 2001
12. Ward S, Harding B, Wilkins P, Harkness W, Hayward R, Darling JL, Thomas DGT, War T: Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32: 59-66, 2001
13. Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison D: Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86: 929-939, 2992
14. Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, Grundy R: Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161: 2133-2141, 2002
15. Jeuken JWM, Sprenger SHE, Gilhuis J, Teepen HLJM, Grotenhuis AJ, Wesseling P: Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. J Pathol 197: 238-244, 2002
16. Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis. Trends Genet 16: 168-174, 2000
17. Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, Lomas J, de Campos JM, Isla A, Sarasa JL, Rey JA: Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 144: 134-142, 2003
18. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229, 2001.
19. Gonzalez-Gomez P, Bello MJ, Arjona D, Lomas J, Alonso ME, de Campos JM, Vaquero J, Isla A, Gutierrez M, Rey JA: Promoter hypermethylation of multiple genes in astrocytic gliomas. Int J Oncol 22: 601-608, 2003
20. Dong S-M, Pang JC-S, Poon W-S, Hu J, Yo, K-F, Chang AR, Ng H-K: Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol 60: 808-816, 2001
21. Watanabe T, Huang H, Nakamura M, Wischhusen J, Weller M, Kleihues P, Ohgaki H: Methylation of p73 gene in gliomas. Acta Neuropathol 104: 357-362, 2002
22. Uhlmann K, Rohde K, Zeller C, Szymas J, Vogel S, Marczinek K, Thiel G, Nürnberg P, Laird PW: Distinct methylation profiles of glioma subtypes. Int J Cancer 106: 52-59, 2003
23. Herman JG, Graff JR, Myohannen S, Nelkin BD, Baylin BD: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996
24. Rey JA, Bello MJ, Jimenez-Lara A, Vaquero J, Kusak ME, de Campos JM, Sarasa JL, Pestaña A: Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer 51: 703-706, 1992
25. Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minnan JD: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249-255, 2001
26. Kang GH, Shim Y-H, Jung H-Y, Kim WH, Ro JY, Rhyu M-G: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61: 2847-2851, 2001
27. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG: Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 59: 3352-3356, 1999
28. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE: Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 60: 1211-1216, 2000
29. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ: Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6: 529-535, 2000
30. Kino T, Takeshima H, Nakao M, Nishi T, Yamamoto K, Kimura T, Saito Y, Kochi M, Kuratsu J, Saya H, Ushio Y: Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes to Cells 6: 441-454, 2001
31. Gonzalez-Gomez P, Bello MJ, Alonso ME, Arjona D, Lomas J, de Campos JM, Isla A, Rey JA: CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours. Br J Cancer 88: 109-114, 2003
32. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JPJ: Alterations in the DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196, 1998
33. Yin D, Xie D, Hofmann W-K, Miller CW, Black KL, Koeffler HP: Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors. Oncogene 21: 8372-8378, 2003
34. Gonzalez-Gomez P, Bello MJ, Lomas J, Arjona D, Alonso ME, Amiñoso C, de Campos JM, Vaquero J, Sarasa JL, Casartelli C, Rey JA: Epigenetic changes in pilocytic astrocytomas and medulloblastomas. Int J Mol Med 11: 655-660, 2003
35. Gonzalez-Gomez P, Bello MJ, Lomas J, Arjona D, Alonso ME, Amiñoso C, Lopez-Marin I, Anselmo NP, Sarasa JL, Gutierrez J, Casartelli C, Rey JA: Aberrant methylation of multiple genes in neuroblastic tumours: relationship with MYCN amplification and allelic status at 1p. Eur J Cancer 39: 1478-1485, 2003
36. 6-alkylguanine-DNA alkyltransferase regulation and importance in response to alkylating carcinogenic and therapeuthic agents. Cancer Res 50: 6119-6129, 1990
37. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. The New Engl J Med 343: 1350-1354, 2000
38. Nakamura M, Watanabe T, Yonekawa Y, Kleihues P, Ohgaki H: Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C → A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis 22: 1715-1719, 2001
39. Bachman KE, Herman JG, Corn PG, Merlo PG, Costello JF, Cavenee WK, Baylin SB, Graff JR: Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers. Cancer Res 59: 798-802, 1999
40. Roberts D: Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 10: 1183-1191, 1996
41. Makos M, Nelkin BD, Reiter R, Linehan M, Brooks J, Isaacs W, Baylin SB: Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res 53: 2719-2722, 1993
42. Dong S, Pang JC, Hu J, Zhou L, Ng H: Transcriptional inactivation of TP73 expression in oligodendroglial tumors. Int J Cancer 98: 370-375, 2002
43. Gonzalez-Gomez P, Bello MJ, Alonso ME, Lomas J, Arjona D, de Campos JM, Vaquero J, Isla A, Lassalatte L, Gutierrez M, Sarasa JL, Rey JA: CpG island methylation in sporadic and neurofibromatosis type 2-associated schwannomas. Clin Cancer Res 9: 5601-5606, 2003